Heemskerk, J. W., Bevers, E. M., & Lindhout, T. (2002). Platelet activation and blood coagulation. Thrombosis and Haemostasis, 88(2), 186–193.

PubMed  Google Scholar 

Bluteau, D., Lordier, L., Di Stefano, A., Chang, Y., Raslova, H., Debili, N., & Vainchenker, W. (2009). Regulation of megakaryocyte maturation and platelet formation. Thrombosis and Haemostasis, 7(Suppl 1), 227–234. https://doi.org/10.1111/j.1538-7836.2009.03398.x

Article  Google Scholar 

Golebiewska, E. M., & Poole, A. W. (2015). Platelet secretion: From haemostasis to wound healing and beyond. Blood Reviews, 29(3), 153–162. https://doi.org/10.1016/j.blre.2014.10.003

Article  PubMed  PubMed Central  Google Scholar 

Aleksandrowicz, K., Hempel, D., Polityńska, B., Wojtukiewicz, A. M., Honn, K. V., Tang, D. G., & Wojtukiewicz, M. Z. (2024). The complex role of thrombin in cancer and metastasis: Focus on interactions with the immune system. Seminars in Thrombosis and Hemostasis, 50(3), 462–473. https://doi.org/10.1055/s-0039-1701062

Article  PubMed  Google Scholar 

Taucher, S., Salat, A., Gnant, M., Kwasny, W., Mlineritsch, B., Menzel, R. C., Schmid, M., Smola, M. G., Stierer, M., Tausch, C., Galid, A., Steger, G., & Jakesz, R. (2003). Impact of pretreatment thrombocytosis on survival in primary breast cancer. Thrombosis and Haemostasis, 89(6), 1098–1106.

Article  PubMed  Google Scholar 

Stravodimou, A., & Voutsadakis, I. A. (2013). Pretreatment thrombocytosis as a prognostic factor in metastatic breast cancer. International Journal of Breast Cancer, 2013, Article 289563. https://doi.org/10.1155/2013/289563

Article  PubMed  PubMed Central  Google Scholar 

Stone, R. L., Nick, A. M., McNeish, I. A., Balkwill, F., Han, H. D., Bottsford-Miller, J., Rupairmoole, R., Armaiz-Pena, G. N., Pecot, C. V., Coward, J., Deavers, M. T., Vasquez, H. G., Urbauer, D., Landen, C. N., Hu, W., Gershenson, H., Matsuo, K., Shahzad, M. M., King, E. R., Tekedereli, I., (...), Sood, A. K. (2012). Pretreatment thrombocytosis in advanced ovarian cancer. Abstract presented at the ECCO Congress. Paraneoplastic thrombocytosis in ovarian cancer. New England Journal of Medicine, 366(7), 610–618. https://doi.org/10.1056/NEJMoa1110352

Słabuszewska-Jóźwiak, A., Dmoch-Gajzlerska, E., Kozakiewicz, B., & Jakiel, G. (2015). The prognostic significance of thrombocytosis in ovarian cancer. Annals of Agricultural and Environmental Medicine, 22(4), 731–735.

Article  PubMed  Google Scholar 

Symbas, N. P., Townsend, M. F., El-Galley, R., Keane, T. E., Graham, S. D., & Petros, J. A. (2000). Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. BJU International, 86(3), 203–207. https://doi.org/10.1046/j.1464-410x.2000.00792.x

Article  PubMed  Google Scholar 

Todenhöfer, T., Renninger, M., Schwentner, C., Stenzl, A., & Gakis, G. (2012). A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors. The British Journal of Urology International, 110(11 Pt B), E533–E540. https://doi.org/10.1111/j.1464-410X.2012.11093.x

Article  Google Scholar 

Hernandez, E., Lavine, M., Dunton, C. J., Gracely, E., & Parker, J. (1992). Poor prognosis associated with thrombocytosis in patients with cervical cancer. Cancer, 69(12), 2975–2977.

Article  PubMed  Google Scholar 

Maráz, A., Furák, J., Varga, Z., Kahán, Z., Tiszlavicz, L., & Hideghéty, K. (2013). Thrombocytosis has a negative prognostic value in lung cancer. Anticancer Research, 33(4), 1725–1729.

PubMed  Google Scholar 

Shimada, H., Oohira, G., Okazumi, S., Matsubara, H., Nabeya, Y., Hayashi, H., Takeda, A., Gunji, Y., & Ochiai, T. (2004). Thrombocytosis associated with poor prognosis in patients with esophageal carcinoma. Journal of the American College of Surgeons, 198(5), 737–741. https://doi.org/10.1016/j.jamcollsurg.2004.01.022

Article  PubMed  Google Scholar 

Aminian, A., Karimian, F., Mirsharifi, R., Alibakhshi, A., Dashti, H., Jahangiri, Y., Safari, S., Ghaderi, H., Noaparast, M., Hasani, S. M., & Mirsharifi, A. (2011). Significance of platelet count in esophageal carcinomas. Saudi Journal of Gastroenterology, 17(2), 134–137.

Article  PubMed  PubMed Central  Google Scholar 

Hwang, S. G., Kim, K. M., Cheong, J. H., Kim, H. I., An, J. Y., Hyung, W. J., & Noh, S. H. (2012). Impact of pretreatment thrombocytosis on blood-borne metastasis and prognosis of gastric cancer. European Journal of Surgical Oncology, 38(7), 562–567. https://doi.org/10.1016/j.ejso.2012.04.009

Article  PubMed  Google Scholar 

Ikeda, M., Furukawa, H., Imamura, H., Shimizu, J., Ishida, H., Masutani, S., Tatsuta, M., & Satomi, T. (2002). Poor prognosis associated with thrombocytosis in patients with gastric cancer. Annals of Surgical Oncology, 9(3), 287–291. https://doi.org/10.1007/BF02573067

Article  PubMed  Google Scholar 

Wang, L., Huang, X., Chen, Y., Jin, X., Li, Q., & Yi, T. N. (2012). Prognostic value of TP/PD-ECGF and thrombocytosis in gastric carcinoma. European Journal of Surgical Oncology, 38(7), 568–573. https://doi.org/10.1016/j.ejso.2012.04.008

Article  PubMed  Google Scholar 

Seo, H. Y., Park, J. M., Park, K. H., Kim, S. J., Oh, S. C., Kim, B. S., Kim, Y. H., & Kim, J. S. (2010). Prognostic significance of serum vascular endothelial growth factor per platelet count in unresectable advanced gastric cancer patients. Japanese Journal of Clinical Oncology, 40(12), 1147–1153.

Article  PubMed  Google Scholar 

Rothwell, P.M., Wilson, M., Price, J.F., Belch, J.F., Meade, T.W., & Mehta, Z. (2012). Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet Oncology, 28;379(9826):1591–601.

Chen, W.Y., Ballman, K.V., Partridge, A.H., Hahn, O.M., Briccetti, F.M., Irvin, W.J., Symington, B., Visvanathan, K., Pohlmann, P.R., Openshaw, T.H., Weiss, A., Winer, E.P., Carey, L.A., & Holmes, M.D. (2024). Aspirin vs placebo as adjuvant therapy for breast cancer: The Alliance A011502 randomized trial. Journal of the American Medical Association, 28;331(20):1714–1721.

McNeil, J.J., Gibbs, P., Orchard, S.G., Lockery, J.E., Bernstein, W.B., Cao, Y., Ford, L., Haydon, A., Kirpach, B., Macrae., F., McLean, C., Millar, J., Murray, A.M., Nelson, M.R., Polekhina., G., Reid, C.M., Richmond, E., Rodríguez, L.M., (...), ASPREE Investigator Group. (2021). Effect of aspirin on cancer incidence and mortality in older adults. Journal of National Cancer Investigation; 113(3):258-265. https://doi.org/10.1093/jnci/djaa114

Lambert, A. W., Pattabiraman, D. R., & Weinberg, R. A. (2017). Emerging biological principles of metastasis. Cell, 168(4), 670–691. https://doi.org/10.1016/j.cell.2016.11.037

Article  PubMed  PubMed Central  Google Scholar 

Lucotti, S., Cerutti, C., Soyer, M., Gil-Bernabé, A. M., Gomes, A. L., Allen, P. D., Smart, S., Markelc, B., Watson, K., Armstrong, P. C., Mitchell, J. A., Warner, T. D., Ridley, A. J., & Muschel, R. J. (2019). Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2. Journal of Clinical Investigation, 129(5), 1845–1862. https://doi.org/10.1172/JCI121985

Article  PubMed  PubMed Central  Google Scholar 

Wang, Y., Sun, Y., Li, D., Zhang, L., Wang, K., Zuo, Y., Gartner, T. K., & Liu, J. (2013). Platelet P2Y12 is involved in murine pulmonary metastasis. PLoS ONE, 8(12), Article e80780. https://doi.org/10.1371/journal.pone.0080780

Article  PubMed  PubMed Central  Google Scholar 

Gebremeskel, S., LeVatte, T., Liwski, R. S., Johnston, B., & Bezuhly, M. (2015). The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer. International Journal of Cancer, 136(1), 234–240. https://doi.org/10.1002/ijc.28947

Article  PubMed  Google Scholar 

Ward, Y., Lake, R., Faraji, F., Sperger, J., Martin, P., Gilliard, C., Ku, K. P., Rodems, T., Niles, D., Tillman, H., Yin, J., Hunter, K., Sowalsky, A. G., Lang, J., & Kelly, K. (2018). Platelets promote metastasis via binding tumor CD97 leading to bidirectional signaling that coordinates transendothelial migration. Cell Reports, 23(3), 808–822. https://doi.org/10.1016/j.celrep.2018.03.092

Article  PubMed  Google Scholar 

White, J. G. (1968). Effects of colchicine and Vinca alkaloids on human platelets. I. Influence on platelet microtubules and contractile function. American Journal of Pathology, 53(2), 281–291.

PubMed  PubMed Central  Google Scholar 

White, J. G. (1972). Interaction of membrane systems in blood platelets. American Journal of Pathology, 66(2), 295–312.

PubMed  PubMed Central  Google Scholar 

King, S. M., & Reed, G. L. (2002). Development of platelet secretory granules. Seminars in Cell and Developmental Biology, 13(4), 293–302. https://doi.org/10.1016/s1084-9521(02)00059-9

Article  PubMed  Google Scholar 

Vizcaino-Salazar, G. (1994). Platelet physiology: Advances in platelet reactivity. Investigación Clínica, 35(1), 41–62.

PubMed  Google Scholar 

Poddar, M., & Banerjee, S. (2020). Molecular aspects of pathophysiology of platelet receptors. In Platelets (pp. 1–18). IntechOpen. https://doi.org/10.5772/intechopen.92856

Colman, R. W. (1990). Platelet receptors. Hematology/Oncology Clinics of North America, 4(1), 27–42. PMID: 2155904.

Article  PubMed  Google Scholar 

Blair, P., & Flaumenhaft, R. (2009). Platelet α-granules: Basic biology and clinical correlates. Blood Reviews, 23(4), 177–189.

Article  PubMed  PubMed Central  Google Scholar 

Wen, Q., Goldenson, B., & Crispino, J. D. (2011). Normal and malignant megakaryopoiesis. Expert Review of Molecular Medicine, 13, Article e32. https://doi.org/10.1017/S1462399411002047

Article  Google Scholar 

Saluk, J., Bijak, M., Ponczek, M. B., & Wachowicz, B. (2014). Powstawanie, metabolizm i ewolucja płytek krwi. Postępy Higieny i Medycyny Doświadczalnej, 68, 384–391.

Article  PubMed  Google Scholar 

Stegner, D., VanEeuwijk, J. M. M., Angay, O., Gorelashvili, M. G., Semeniak, D., Pinnecker